Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs

<< Previous

Bullboard Posts

Next >>

Post by The300on Mar 01, 2011 4:25pm

263 Views

Post# 18214744

National and Anon At It Again

It looks like we can't gain any traction with the recent buying from yesterday and today as National and Anonymous are pouncing on any bid over $.50.

It looks like it is disciplined selling as they are not looking to kill the stock, but definitely looks like they have a mandate to get anything over $.50 for their stock.

We need to clear out whoever it is behind the selling before we see any upward movement. Tough to say if it is Mineral Fields as they no longer report to SEDI, but I think that would be my guess.

With current drilling program underway on 100% owned Sherridon property, updated 43-101 and decision to take Cold-Lost into production pending (all of this likely to take place in March or early April), I can't imagine we have too many retail investors looking for the exits.

As always, IMHO

Regards,

The 300

<< Previous

Bullboard Posts

Next >>

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!